Literature DB >> 19101768

Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.

John Rescigno1, Jamie C Zampell, Deborah Axelrod.   

Abstract

BACKGROUND: Population-based overall patterns of surgical management of the axilla in women with operable breast cancer during the era of adoption of sentinel lymph node biopsy (SLNB) were studied.
METHODS: Women with operable breast carcinoma residing in 14 geographic areas of the Surveillance, Epidemiology, and End Results (SEER) cancer registries (1998-2004, n=239,661) were assessed for axillary surgical patterns of care.
RESULTS: Use of SLNB increased from 11 to 59%. Use of no axillary surgery decreased from 14 to 6.6%. In pathologic node-negative women, use of axillary lymph node dissection (ALND) decreased from 94 to 36%. Independent factors most associated with failure to receive SLNB included diagnosis year (2000: 62%; 2004: 29%), surgery (mastectomy: 64%; breast-conserving surgery: 36%), tumor size (T3: 71%; T2: 56%; T1: 40%), age (>or= 70 years: 50%; <70 years: 45%), grade (high: 42%; low: 38%), urbanity (non-large metropolitan area: 49%; large metropolitan area: 42%), and, by quartile, poverty (highest: 47%; lowest: 35%), and white-collar employment (lowest: 56%; highest: 47%). In pathologic node-positive women who had SLNB, failure to undergo completion ALND increased from 20% in 1998 to 32% in 2004. Patients with smaller, lower-grade tumors, and those with smaller size of nodal metastasis, lack of extracapsular extension, age >or= 70 years, increased linguistic isolation, African-American or Hispanic race/ethnicity, and white-collar employment were less likely to undergo completion ALND.
CONCLUSIONS: Management of the axilla changed dramatically during the period of rapid adoption of SLNB. Patterns of care suggest both appropriate and inappropriate selection for SLNB and ALND.

Entities:  

Mesh:

Year:  2008        PMID: 19101768     DOI: 10.1245/s10434-008-0195-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  27 in total

Review 1.  The need for axillary dissection in patients with positive axillary sentinel lymph nodes.

Authors:  Randal L Croshaw; Kathleen M Erb; Hilary M Shapiro-Wright; Thomas B Julian
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

2.  Nine years of experience with the sentinel lymph node biopsy in a single Italian center: a retrospective analysis of 1,050 cases.

Authors:  Sergio Bernardi; Serena Bertozzi; Ambrogio P Londero; Francesco Giacomuzzi; Vito Angione; Cinzia Dri; Arnalda Carbone; Roberto Petri
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

3.  Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

4.  Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.

Authors:  Tina W F Yen; Purushottam W Laud; Liliana E Pezzin; Emily L McGinley; Erica Wozniak; Rodney Sparapani; Ann B Nattinger
Journal:  Med Care       Date:  2018-01       Impact factor: 2.983

5.  Quality indicators for sentinel lymph node biopsy: is there room for improvement?

Authors:  Sergio A Acuna; Fernando A Angarita; David R McCready; Jaime Escallon
Journal:  Can J Surg       Date:  2013-04       Impact factor: 2.089

6.  Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?

Authors:  Catherine E Loveland-Jones; Karen Ruth; Elin R Sigurdson; Brian L Egleston; Marcia Boraas; Richard J Bleicher
Journal:  Breast Cancer Res Treat       Date:  2014-01-19       Impact factor: 4.872

7.  Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.

Authors:  Rehana L Ahmed; Kathryn H Schmitz; Anna E Prizment; Aaron R Folsom
Journal:  Breast Cancer Res Treat       Date:  2011-07-15       Impact factor: 4.872

8.  Predictors and outcomes of completion axillary node dissection among older breast cancer patients.

Authors:  Sara H Javid; Hao He; Larissa A Korde; David R Flum; Benjamin O Anderson
Journal:  Ann Surg Oncol       Date:  2014-03-01       Impact factor: 5.344

9.  Understanding age and race disparities in the application of sentinel lymph node biopsy in breast cancer.

Authors:  Archana Radhakrishnan; Paula Silverman; Craig Evan Pollack; Elizabeth R Pfoh; Robert Shenk; Cheryl L Thompson
Journal:  J Investig Med       Date:  2016-07-27       Impact factor: 2.895

10.  Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.

Authors:  Tina W F Yen; Purushuttom W Laud; Rodney A Sparapani; Ann B Nattinger
Journal:  JAMA Surg       Date:  2014-02       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.